¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"receptors, vasopressin"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® vasopressin ÇÑ±Û ¹Ù¼ÒÇÁ·¹½Å
¼³¸í   
  ½Ã»óÇϺΠ½Å°æÇÙÀÇ ½Å°æ¼¼Æ÷¿¡¼­ ¸¸µé¾îÁö¸ç, ³úÇϼöü ÈÄ¿±¿¡ ÀúÀåµÇ´Â 2Á¾ÀǠȣ¸£¸ó ÁßÀÇ Çϳª. Ç×ÀÌ´¢È£¸£¸ó(antidiuretic hormone, ADH)À̶ó°íµµ ÇÑ´Ù. ´Ù¸¥ 1Á¾Àº ¿Á½ÃÅä½ÅÀÌ´Ù. ¸ð¼¼Ç÷°ü°ú ¼¼µ¿¸ÆÀ» ±¸¼ºÇϴ ÆòȰ±Ù Á¶Á÷ÀÇ ¼öÃàÀ» ÀÚ±ØÇÏ¿© Ç÷¾ÐÀ» »ó½Â½Ã۴ ÀÛ¿ëÀÌ ÀÖ´Ù. Ã¢ÀÚ±ÙÀ°ÀÇ ¼öÃàÀ» ÀÚ±ØÇϰí, ²ÞƲ¿îµ¿À» Áõ°­½Ã۸ç, Àڱÿ¡µµ ¿µÇâÀ» ÁØ´Ù. ¶ÇÇÑ ¿ä¼¼°ü ¿øÀ§ºÎÀÇ »óÇǼ¼Æ÷¿¡ Æ¯¼öÇÑ ÀÛ¿ëÀ» ÀÏÀ¸ÄÑ, °íÇü¹°ÀÇ Èí¼ö¿Í´Â °ü°è¾øÀÌ ¼öºÐÀÇ ÀçÈí¼ö¸¦ Ç×Áø½ÃÄÑ ¿ÀÁÜÀ» ³óÃà½ÃŲ´Ù. ¹Ù¼ÒÇÁ·¹½ÅÀº ÇÕ¼º¿¡ ÀÇÇØ¼­µµ ¸¸µé¾îÁö°í, ¶ÇÇÑ °¡ÃàÀÇ Çϼöü ÈÄ¿±À¸·ÎºÎÅ͵µ ¾ò¾îÁö¸ç, Ç×ÀÌ´¢Á¦·Î¼­ ÁÖ»ç¾×À¸·Îµµ »ç¿ëµÈ´Ù. °í¸® ¸ð¾çÀ¸·Î Æú¸®ÆéƼµå°áÇÕÀ» ÀÌ·é´Ù. Æ÷À¯·ù¿¡¼­ ±¤¹üÀ§ÇϰԠº¼ ¼ö Àִ °ÍÀ¸·Î ÄáÆÏ¿¡¼­ ¼öºÐÀÇ ÀçÈí¼ö¸¦ ÃËÁøÇϴ ¹°Áú·Î ÀÛ¿ëÇÑ´Ù. ¸ð¼¼Ç÷°üÀ» ¼öÃà½ÃÄÑ Ç÷¾ÐÀ» ³ôÀ̴ ÀÛ¿ëÀÌ ÀÖÀ¸¹Ç·Î ÀúÇ÷¾Ð Ä¡·á¿¡ ÀÌ¿ëµÈ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Desamino-8-7-arginine vasopressin
    ÀÏ-µ¥½º¾Æ¹Ì³ë-ÆÈ-Ä¥-¾Æ¸£±â´Ñ¹Ù¼ÒÇÁ·¹½Å
  • arginine vasopressin
    ¾Ë±â´Ñ ¹Ù¼ÒÇÁ·¹½Å, ¾ËÁö´Ñ ¹Ù¼ÒÇÁ·¹½Å
  • GABA A receptors
    GABA A ¼ö¿ëü(áôé»ô÷)
  • GABA receptors
    GABA ¼ö¿ëü(áôé»ô÷)
  • GABAB receptors
    GABA B ¼ö¿ëü(áôé»ô÷)
  • H1 receptors
    H1¼ö¿ëü(â¥é»ô÷)
  • HT receptors
    5-ÇÏÀ̵å·Ï½ÃÆ®¸³Å¸¹Î¼ö¿ëü
  • HT2 receptors, action of hallucinogens
    5-ÇÏÀ̵å·Ï½ÃÆ®¸³Å¸¹Î2¼ö¿ëü
  • Hair follicle receptors
    ¸ð³¶¼ö¿ëü(Ù¾Ò¥â¥é»ô÷)
  • Hair receptors
    ¸ð¼ö¿ëü(Ù¾â¥é»ô÷)
  • Heat receptors
    ¿­¼ö¿ëü(æðâ¥é»ô÷)
  • Histamine receptors
    È÷½ºÅ¸¹Î¼ö¿ëü
  • Immunoglobulin adhesion receptors
    ¸é¿ª±Û·ÎºÒ¸° ºÎÂø(ݾó·)¼ö¿ëü
  • Irritant receptors, ventilatory responses , ventilatory responses
    Àڱؼö¿ëü(í©Ð½áôé»ô÷), È£Èí¹ÝÀÀ(û¼ýåÚãëë)
  • J receptors, ventilatory responses mediated
    J ¼ö¿ëü(áôé»ô÷), È£Èí¹ÝÀÀ(û¼ýåÚãëë)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arginine vasopressin
    ¾Ë±â´Ñ ¹Ù¼ÒÇÁ·¹½Å, ¾ËÁö´Ñ ¹Ù¼ÒÇÁ·¹½Å
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å.
  • vasopressin deficiency
    ¹Ù¼ÒÇÁ·¹½Å°áÇÌÁõ(¡­ÌÀù¹ñø).
  • vasopressin deficiency
    ¹Ù¼ÒÇÁ·¹½Å°áÇÌÁõ(¡­ÌÀù¹ñø)
  • atrial receptors
    (½É)¹æ¼ö¿ëü(¡­áôé»ô÷)
  • atrial receptors
    ½É¹æ¼ö¿ëü(¡­áôé»ô÷).
  • down-regulation (of receptors)
    (¼ö¿ëü)ÇÏÇâÁ¶Àý.
  • down-regulation (of receptors)
    ¼ö¿ëü(áôé»ô÷)ÇÏÇâÁ¶Àý(ù»ú¾ðàï½).
  • presynaptic receptors
    ½Å°æÁ¢ÇÕÀü ¼ö¿ëü
  • receptors
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arginine vasopressin
    ¾Æ¸£Áö´Ñ ¹Ù¼ÒÇÁ·¹½Å
  • lysine vasopressin
    ¶óÀ̽Š¹Ù¼ÒÇÁ·¹½Å
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AVP abnormal vasopressin; actinomycin-vincristine-Platinol; ambulatory venous pressure; antiviral protei...
DDAVP, dDAVP 1-deamino-8-D-arginine vasopressin; 1-deamino-8-N-arginine vasopressin
AChRs Acetylcholine Receptors
RA radioactive; ragocyte; ragweed antigen; rapidly adapting [receptors]; reactive arthritis; reciprocal...
ADH   1) Aldehyde De-Hydrogenase
    = ALDH
  2) Anti-Diur...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DDAVP 1,desamino-8-D-arginine vasopressin
AVP 3)H]arginine vasopressin
3H-AVP 3H-arginine-vasopressin
AVP 8-Arg]-vasopressin
AVP 8-Arginine vasopressin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å, ¹ÙÁ¶ÇÁ·¹½Å
    1. ½Ã»óÇϺΠ½Å°æÇÙÀÇ ½Å°æ ¼¼Æ÷¿¡¼­ ¸¸µé¾îÁö¸ç, ³úÇϼöü ÈÄ¿±¿¡ ÀúÀåµÇ´Â 2Á¾ÀÇ È£¸£¸ó ÁßÀÇ Çϳª. ´Ù¸¥ 1Á¾Àº ¿Á½ÃÅä½ÅÀÌ´Ù. ¸ð¼¼Ç÷°ü°ú ¼¼µ¿¸ÆÀ» ±¸¼ºÇÏ´Â ÆòȰ±Ù Á¶Á÷ÀÇ ¼öÃàÀ» ÀÚ±ØÇÏ¿© Ç÷¾ÐÀ» »ó½Â½ÃŰ´Â ÀÛ¿ëÀÌ ÀÖ´Ù. Àå°ü±ÙÀÇ ¼öÃàÀ» ÀÚ±ØÇϰí, ¿¬µ¿À» Áõ°­½Ã۸ç, Àڱÿ¡µµ ¿µÇâÀ» ÁØ´Ù. ¶ÇÇÑ ¼¼´¢°ü ¿øÀ§ºÎÀÇ »óÇǼ¼Æ÷¿¡ Ư¼öÇÑ ÀÛ¿ëÀ» ÀÏÀ¸ÄÑ, °íÇü¹°ÀÇ Èí¼ö¿Í´Â °ü°è¾øÀÌ ¼öºÐÀÇ ÀçÈí¼ö¸¦ Ç×Áø½ÃÄÑ ¿ä¸¦ ³óÃà½ÃŲ´Ù. ¹Ù¼ÒÇÁ·¹½ÅÀº ÇÕ¼º¿¡ ÀÇÇØ¼­µµ ¸¸µé¾îÁö¸ç, ¶ÇÇÑ °¡ÃàÀÇ Çϼöü ÈÄ¿±À¸·ÎºÎÅ͵µ ¾ò¾îÁö¸ç, Ç×ÀÌ´¢Á¦·Î¼­ ÁÖ»ç¾×À¸·Î »ç¿ëµÈ´Ù. 2. Ç÷°üÀÇ ÆòȰ±ÙÀ» ¼öÃà½ÃŰ¹Ç·Î ¸»ÃÊÀúÇ×ÀÌ Ä¿Á®¼­ Ç÷¾ÐÀÌ »ó½ÂµÈ´Ù. ¶ÇÇÑ ½ÅÀå¿¡¼­ ¿ÀÁÜÀ» ³óÃà½ÃÄÑ ¼öºÐÀÇ ¹è¼³À» ¾ïÁ¦½ÃŲ´Ù. 3. ³úÇϼöü ÈÄ¿±¿¡¼­ ºÐºñµÇ´Â È£¸£¸ó. Ç×ÀÌ´¢ È£¸£¸óÀ̶ó°íµµ ÇÑ´Ù. Ç×ÀÌ´¢ ÀÛ¿ë°ú Ç÷¾Ð »ó½ÂÀÛ¿ëÀÌ ÀÖ´Ù. Ç÷°ü
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
receptors, vasopressin Specific molecular sites or structures on or in cells that vasopressins react or to which they bind in order to modify the function of the cells. Two types of vasopressin receptor exist, the v1 receptor and the v2 receptor. The v1 receptor can be subdivided into v1a and v1b (formerly v3) receptors.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
arginine vasopressin [8-arginine]vasopressin; [Arg8]vasopressin;vasopressin containing an arginyl residue in position 8 (as in chickens and most mammals, including man); porcine vasopressin has a lysyl residue at position 8. All are vasopressors.
Synonym: argipressin.
(05 Mar 2000)
vasopressin <protein> A peptide hormone released from the posterior pituitary lobe but synthesised in the hypothalamus. There are 2 forms, differing only in the amino acid at position 8: arginine vasopressin is widespread, while lysine vasopressin is found in pigs. Has antidiuretic and vasopressor actions. Used in the treatment of diabetes insipidus.
(18 Nov 1997)
vasopressin-converting aminopeptidase <enzyme> Activity found in brain which converts vasopressin into centrally active metabolites
Registry number: EC 3.4.11.-
Synonym: vp-c aminopeptidase
(26 Jun 1999)
vasopressin level This test measures the amount of ADH in the serum. It is used to detect disorders that may affect the level of ADH in the serum. Normal values are: 0 to 4.7 pg/ml. Elevated ADH levels can indicate a CNS infection, fluid imbalance, CNS tumour, SIADH or acute porphyria. Low levels can indicate: diabetes insipidus or damage to the pituitary gland.
(27 Sep 1997)
vasopressin-resistant diabetes Diabetes insipidus due to inability of the kidney tubules to respond to antidiuretic hormone; X-linked inheritance, with full expression in males and partial defect in heterozygous females.
Synonym: vasopressin-resistant diabetes.
(05 Mar 2000)
unit of vasopressin The pressor activity of 0.5 mg of the USP Posterior-pituitary Reference Standard; 1 mg of synthetic vasopressin corresponds to 600 IU.
(05 Mar 2000)
8-lysine vasopressin <chemical> 8-lysyl vasopressin. The porcine antidiuretic hormone most frequently used clinically. A cyclic nonapeptide with lysine in position 8 of the chain; it is used to treat diabetes insipidus and as haemostatic because of its vasoconstrictor action.
Pharmacological action: haemostatics, renal agents, vasoconstrictor agents.
Chemical name: Vasopressin, 8-L-lysine-
(12 Dec 1998)
adrenergic receptors Reactive components of effector tissues, most of which are innervated by adrenergic postganglionic fibres of the sympathetic nervous system. Such receptor's can be activated by norepinephrine and/or epinephrine and by various adrenergic drugs; receptor activation results in a change in effector tissue function, such as contraction of arteriolar muscles or relaxation of bronchial muscles; adrenergic receptor's are divided into alpha-receptor's and beta-receptor's, on the basis of their response to various adrenergic activating and blocking agents.
Synonym: adrenoceptor, adrenoreceptors.
(05 Mar 2000)
alpha-adrenergic receptors Adrenergic receptor's in effector tissues capable of selective activation and blockade by drugs; conceptually derived from the ability of certain agents, such as phenoxybenzamine, to block only some adrenergic receptor's and of other agents, such as methoxamine, to activate only the same adrenergic receptor's. Such receptor's are designated as alpha-receptors. Their activation results in physiological responses such as increased peripheral vascular resistance, mydriasis, and contraction of pilomotor muscles.
(05 Mar 2000)
ANP clearance receptors Cell surface proteins that bind atrial natriuretic peptide and ANP fragments without initiating biological action.
(05 Mar 2000)
ANP receptors Cell surface receptors for atrial natriuretic peptide that have a single transmembrane spanning element; these have integral kinase and guanylate cyclase domains.
(05 Mar 2000)
B-cell antigen receptors In the primary immune response immunoglobulin D and monomeric immunoglobulin M are the B-cell antigen receptors. On memory B-cells, other immunoglobulin molecules can serve as antigen receptors.
(05 Mar 2000)
beta-adrenergic receptors Adrenergic receptor's in effector tissues capable of selective activation and blockade by drugs; conceptually derived from the ability of certain agents, such as propranolol, to block only some adrenergic receptor's and of other agents, such as isoproterenol, to activate only the same adrenergic receptor's. Such receptor's are designated as beta-receptors. Their activation results in physiological responses such as increases in cardiac rate and force of contraction (b1), and relaxation of bronchial and vascular smooth muscle (b2).
(05 Mar 2000)
mannose-6-phosphate receptors Receptors in Golgi apparatus to which newly synthesised proteins that are destined to enter lysosomes bind.
(05 Mar 2000)
receptors, adrenergic Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of g-proteins with which they bind; this scheme does not respect the alpha-beta distinction.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Receptors, Vasopressin - »õâ Specific molecular sites or proteins on or in cells to which VASOPRESSINS bind or interact in order to modify the function of the cells. Two types of vasopressin receptor exist, the V1 receptor in the vascular smooth muscle and the V2 receptor in the kidneys. The V1 receptor can be subdivided into V1a and V1b (formerly V3) receptors.
    Synonyms : 8-Arg-Vasopressin Receptor, Antidiuretic Hormone Receptor, Antidiuretic Hormone Receptor 1a, Antidiuretic Hormone Receptor 1b, Arginine Vasopressin Receptor, Argipressin Receptor, Argipressin Receptors, Receptor, Arginine(8)-Vasopressin, V1 Receptor
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å(½Å°æ¼º ³úÇϼöüȣ¸£¸óÀÇ ÀÏÁ¾,Ç÷¾Ð »ó½Â,Ç×ÀÌ´¢Á¦)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á